¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tissue space"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • subphrenic space
    °¡·Î¸·¹Ø°ø°£, Ⱦ°Ý¸·Çϰø°£
  • subretinal space
    ¸Á¸·¹Ø°ø°£, ¸Á¸·Çϰø°£
  • superficial perineal space
    ¾èÀº»ô°ø°£, Ç¥ÀçȸÀ½°ø°£
  • suprachoroidal space
    ¸Æ¶ô¸·À§°ø°£, ¸Æ¶ô¸·»ó°ø°£
  • suprasternal space
    º¹ÀåÀ§°ø°£, Èä°ñÀ§°ø°£
  • web space
    °¥Äû¸·°ø°£, Áö°£
  • zonular space
    ¶ì°ø°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • space myopia
    Çã°ø±Ù½Ã
  • palmar space
    ¼Õ¹Ù´Ú°ø°£
  • parapharyngeal space
    (¢¡pharyngomaxillary space) ÀεÎÀ§Åΰø°£
  • parotid space
    ±Í¹Ø»ù°ø°£
  • perichoroidal space
    ¸Æ¶ô¸·ÁÖÀ§°ø°£
  • perilymphatic space
    ¿Ü¸²ÇÁ°ø°£, ¹Ù±ù¸²ÇÁ°ø°£
  • perineurial space
    ½Å°æÁÖÀ§°ø°£
  • peripharyngeal space
    (¢¡retropharyngeal space) Àεεڰø°£
  • periplasmic space
    ¿øÇüÁú¸·ÁÖÀ§°ø°£
  • perisinusoidal space
    ±¼ÁÖÀ§°ø°£
  • peritonsillar space
    ÆíµµÁÖÀ§°ø°£
  • perivitelline space
    ³­È²ÁÖÀ§°ø°£
  • pharyngomaxillary space
    ÀεÎÀ§Åΰø°£
  • phrenicocostal space
    °¡·Î¸·°¥ºñ°ø°£, Ⱦ°Ý¸·´Á°ñ°£°Ý
  • physiologic dead space
    »ý¸®ÇÐÀûÁ×Àº°ø°£
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • pharyngomaxillary space
    Àελó¾Ç°­ (¡­Ë·).
  • phase space
    À§»ó°ø°£(êÈßÓÍöÊà).
  • phrenicocostal space
    Ⱦ°Ý°ñ±Ø.
  • physiologic dead space
    »ý¸®ÇÐÀû »ç°­ (¡­ÞÝË·).
  • physiologic dead space
    »ý¸®ÇÐÀû »ç°­(ßæ×âùÊîÜ ÞÝË·)
  • placental blood space
    ŹÝÇ÷¾×°­ (¡­úìäûË·).
  • placental space
    Źݰ­(¡­Ë·).
  • plantar space
    ¹ß¹Ù´Ú°ø°£, Á·Àú°£±Ø(ðëî¼ÊàÐÀ).
  • pleural space
    È丷°ø°£.
  • popliteal space
    ½½¿Í(ã£èÀ).
  • posterior pharyngeal space
    µÚÀεΰø°£, ÈÄÀεΰ£±Ø(ý­ìÖÔéÊàÐÀ).
  • posterior pharyngeal space
    ÈÄÀεΰ£±Ø, µÚÀεΰø°£{ÇØ}
  • preepiglottic space
    Èĵε¤°³¾Õ°ø°£, Èĵΰ³Àü(°£)±Ø(¡­îñÊàÐÀ).
  • preepiglottic space
    Èĵΰ³Àü(°£)±Ø, Èĵε¤°³¾Õ°ø°£
  • preputial space
    Æ÷ÇDZØ(øÐù«ÐÀ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
VCS vasoconstrictor substance; vesicocervical space
VD vapor density; vascular disease; vasodilation, vasodilator; venereal disease; venous dilatation; ven...
VD dead space
Vd voided, voiding; volume dead space; volume of distribution
Vd/Vt dead space ventilation/total ventilation [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
IAAT Intra-abdominal adipose tissue
LTM Lean tissue mass
M.C.T.D. Mixed Connective Tissue Disease
MALT Mucosa Associated Lymphoid Tissue
NALT Nasal-Associated Lymphoid Tissue
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • disk space
    ¿øÆÇ °­
  • Donder's space
    DonderÀÇ °ø°£
    ÇϾÇÀÌ ¾ÈÁ¤À§¿¡ ÀÖÀ» ¶§, Çô´Â ±¸°­Àú¿¡ À§Ä¡Çϰí, ¼³¹è¿Í ±¸°³ »çÀÌ¿¡ °ø°£ÀÌ »ý±â´Âµ¥, À̸¦ DonderÀÇ °ø°£À̶ó ÇÑ´Ù.
  • double space arthrogram
    ÀÌÁß°­ °üÀý Á¶¿µ »çÁø
  • endolymphatic space
    ¼Ó ¸²ÇÁ °ø°£, ³»¸²ÇÁ °­
  • epidural space
    °æÁú¸· ¹Ù±ù °ø°£, °æ¸·¿Ü±Ø, °æ¸·¿Ü°­
  • extracellular space
    ¼¼Æ÷¿Ü °ø°£, ¼¼Æ÷¿Ü °­
  • fascial space
    ±Ù¸· °£°Ý
  • Fourier space
    Ǫ¸®¾î °ø°£
  • freeway space
    »óÇÏ¾Ç Ä¡¾Æ°£ ÀÚÀ¯ °ø°£, ÀÚÀ¯ °ø±Ø
    ÇϾÇÀÌ ¾ÈÁ¤À§¿¡ ÀÖÀ» ¶§ ¾Ç±Ã°£ÀÇ ±³ÇÕ°£ °Å¸® ¶Ç´Â ºÐ¸®.
  • functional dead space
    ±â´ÉÀû »ç°­
  • Haversian space
    ÇϹö½º °­
    µ¿ÀǾî=Haversian canal, 1. ÇϹö½Ã¾È °èÀÇ Á߽ɰü, Ç÷°ü, ½Å°æ ¹× ¼º±ä °áÇÕÁ¶Á÷µéÀÌ Â÷ ÀÖÀ¸¸ç ÁÖÀ§ÀÇ Á᫐ °üµé°ú´Â Volkman`s canal¿¡ ÀÇÇØ ¿¬°áµÇ¾î ÀÖ´Ù. 2. ÇϹö½º ±¸Á¶ÀÇ ³»ºÎ¿¡ Á¸ÀçÇÏ´Â °ø°£.
  • inferior joint space
    ÇϰüÀý °­
  • infratemporal space
    ÃøµÎÇÏ¿Í ±Ø
  • interdental triangle space
    Ä¡°£ »ï°¢ °£±Ø
    Ä¡¾Æ¿Í Ä¡¾Æ »çÀÌÀÇ ÀÎÁ¢¸é À§ÀÇ Á¢ÃËÁ¡ ÇϹ濡 Çü¼ºµÈ »ï°¢Çü ÇüÅÂÀÇ °ø°£.
  • interocclusal rest space
    ±³ÇÕ ¾ÈÁ¤ °ø±Ø
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
tissue inhibitor-of metalloproteinase-2 <chemical> A member of the family of tissue inhibitor of metalloproteinases. It is a 21 kD nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase a by human fibroblast and uncomplexed from alveolar macrophages. An overexpression of timp-2 has been shown to inhibit invasive and metastatic activity of tumour cells and decrease tumour growth in vivo.
Pharmacological action: antineoplastic agent, protease inhibitors.
(12 Dec 1998)
tissue inhibitor of-metalloproteinase-3 <chemical> A member of the family of tissue inhibitor of metalloproteinases. It is a 21 kD, nonglycosylated protein. Timp-3 does not show a high degree of structural similarity unlike timp-1 and timp-2 which are structurally similar. However, it does possess a high degree of structural similarity with that of chicken timp-3 (chimp-3). Human timp-3 is of particular concern because of its potential role in cancer, arthritis, and eye diseases.
Pharmacological action: antineoplastic agent, protease inhibitors.
(12 Dec 1998)
tissue inhibitor of metalloproteinases <chemical> A family of secreted proteins (timp-1, timp-2, and timp-3) that play a crucial role in regulating the activity of the secreted metalloproteinases (collagenases, stromelysins, gelatinases). Of the three characterised, only timp-1 and timp-2 appear to have related primary structures and inhibitory properties. They influence the activation of the prometalloproteinase and act to modulate proteolysis of extracellular matrix, notably during tissue remodeling and inflammatory processes. On certain cell types, they can exhibit growth factor-like activity, and they can inhibit the tumourigenic and metastatic phenotype in cancer cells. (pharmacol ther 1993;59:329-41)
Pharmacological action: antineoplastic agent, protease inhibitors.
(12 Dec 1998)
tissue inhibitors of metalloproteinase <cell biology> Family of proteins of around 200 residues that can inhibit metalloproteinases, for example collagenase, by binding to them.
(18 Nov 1997)
tissue lymph True lymph, i.e., lymph derived chiefly from fluid in tissue spaces (in contrast to blood lymph).
(05 Mar 2000)
tissue molding The shaping of an impression material by the manipulation or action of the tissues adjacent to the borders of an impression.
Synonym: muscle-trimming, tissue molding, tissue-trimming.
(05 Mar 2000)
tissue perfusion A term that describes blood flow into the tissues. Inadequate tissue perfusion is a clinical syndrome known as shock.
(27 Sep 1997)
tissue plasminogen activator <enzyme> Plasma serine protease, one of a closely related group of plasminogen activators. Contains an EGF like domain and multiple copies of the kringle domain.
(18 Nov 1997)
tissue polypeptide antigen Serological tumour marker composed of a molecular complex of cytokeratins 8, 18, and 19. It is used in the diagnosis and staging of bronchogenic carcinoma.
(12 Dec 1998)
tissue preservation The process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived (i.e., to keep from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).
(12 Dec 1998)
tissue procollagenase <enzyme> Precursor of tissue collagenase; do not confuse with procollagenase, which is the precursor of clostridiopeptidase a
Registry number: EC 3.4.24.-
Synonym: promatrixmetalloproteinase-1, prommp-1, pro-matrix metalloproteinase-1
(26 Jun 1999)
tissue registration In dentistry, the accurate registration of the shape of tissues under any condition by means of a suitable material, an impression.
(05 Mar 2000)
tissue respiration The interchange of gases between the blood and the tissues.
Synonym: internal respiration.
(05 Mar 2000)
tissue-specific antigen A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species.
Synonym: tissue-specific antigen.
(05 Mar 2000)
tissue survival The span of viability of a tissue or an organ.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á